Abstract
President Obama has announced a research initiative that aims to accelerate progress toward a new era of precision medicine, with a near-term focus on cancers and a longer-term aim to generate knowledge applicable to the whole range of health and disease.
Keywords
Precision medicineMedicineAlternative medicineFocus (optics)MEDLINETerm (time)Engineering ethicsPolitical sciencePathologyLaw
MeSH Terms
Biomedical ResearchFinancingGovernmentHealthHumansNeoplasmsPrecision MedicineResearch Support as TopicUnited States
Affiliated Institutions
Related Publications
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Immune checkpoint inhibitors, which unleash a patient’s own T cells to kill tumors, are revolutionizing cancer treatment. To unravel the genomic determinants of response to this...
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
Abstract Background Treatment with immune checkpoint blockade (ICB) with agents such as anti-programmed cell death protein 1 (PD-1), anti-programmed death-ligand 1 (PD-L1), and/...
Immunotherapy in colorectal cancer: rationale, challenges and potential
Following initial successes in melanoma treatment, immunotherapy has rapidly become established as a major treatment modality for multiple types of solid cancers, including a su...
Clinical Significance of Programmed Death-1 Ligand-1 Expression in Patients with Non-Small Cell Lung Cancer: A 5-year-follow-up Study
Aims and background The programmed death-1-ligand 1 (PD-L1) has been recently suggested to play a pivotal role in the immune evasion of tumors from host immune system. In the st...
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Predicting responses to immunotherapy Colon cancers with loss-of-function mutations in the mismatch repair (MMR) pathway have favorable responses to PD-1 blockade immunotherapy....
Publication Info
- Year
- 2015
- Type
- article
- Volume
- 372
- Issue
- 9
- Pages
- 793-795
- Citations
- 4955
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
4955
OpenAlex
137
Influential
4115
CrossRef
Cite This
Francis S. Collins,
Harold Varmus
(2015).
A New Initiative on Precision Medicine.
New England Journal of Medicine
, 372
(9)
, 793-795.
https://doi.org/10.1056/nejmp1500523
Identifiers
- DOI
- 10.1056/nejmp1500523
- PMID
- 25635347
- PMCID
- PMC5101938